Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain
Go back to Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain| Merit Medical Systems, Inc. (NASDAQ: MMSI) | Delayed: 66.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.50 | 52 Week High | $25.10 | |||
| Open | $66.50 | 52 Week Low | $15.47 | |||
| Day High | $66.50 | P/E | 266.00 | |||
| Day Low | $66.50 | EPS | $0.25 | |||
| Volume | 221 | |||||
